Le Lézard
Classified in: Health
Subjects: NPT, VET, FVT

Targeting A Solution Panel Aims to Find Solutions for the Veteran Suicide Crisis with National Thought Leaders Tulsi Gabbard, Tim Kennedy, and Dan Hollaway


KANNAPOLIS, N.C., April 18, 2024 /PRNewswire/ -- Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term Congresswoman, 2020 presidential candidate, and combat Veteran Tulsi Gabbard, former MMA fighter, Green Beret and entrepreneur Tim Kennedy, and podcaster, Veteran, and thought leader Dan Hollaway

On average, 17 Veterans died by suicide per day in 2023. The Independence Fund, a Charlotte, NC-based Veteran non-profit, is committed to facing the Veteran suicide epidemic head-on. As a national Veteran Service Organization, The Independence Fund has developed multiple programs dedicated to the physical and mental health of Veterans. 

"Targeting a Solution is about returning purpose and meaning to a generation of warfighters who answered the call when America needed them," said Dan Hollaway, Veteran, panelist, and podcaster. "It is my sincere pleasure to be part of this special event to spread awareness and action on a critical issue plaguing the Veteran community."

The Targeting a Solution panel is taking place over the weekend dedicated to honoring the Fourth annual celebration of the statewide holiday, Wounded Heroes Day. Wounded Heroes Day was signed into law on April 24th, 2021, in honor of SGT Michael Verardo, who survived catastrophic injuries in Afghanistan on April 24th, 2010. Wounded Heroes Day honors SGT Verardo and all wounded Veterans across North Carolina for their immeasurable sacrifice. 

"Michael's injury on April 24th, 2010, changed life for my family forever, and this state-recognized day is a meaningful way we can honor the sacrifices of so many of our local friends and neighbors who have experienced the same," says Sarah Verardo, CEO of The Independence Fund and wife of SGT Michael Verardo. "Being able to continue the conversation about the Veteran suicide epidemic and work together toward our common goal with the strong voices of Tim Kennedy, Tulsi Gabbard, and Dan Hollaway helps us do that, which gives the weekend even more meaning." 

Tickets to attend the panel and other events of the weekend honoring Wounded Heroes Day can be reserved at WoundedHeroesDay.org.

ABOUT THE INDEPENDENCE FUND: 
Founded in 2007, The Independence Fund (501c3) is committed to serving United States Veterans by providing innovative programs and services to support the physical, mental, emotional, and spiritual independence of servicemembers, combat Veterans, their Caregivers, families, and those Allies who served in combat alongside American troops, through innovative mobility and adaptive technologies and therapies for combat Veterans; suicide prevention; caregiver and family support; and Veteran advocacy with the U.S. Department of Veterans Affairs, other government agencies, federal and state legislators, and other partners.

Media contact:
[email protected]

SOURCE The Independence Fund


These press releases may also interest you

at 16:20
Butterfly Network, Inc. ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced financial results for the first quarter ended March 31, 2024, and...

at 16:20
Mirum Pharmaceuticals, Inc. today announced that it will report first quarter 2024 financial results on May 8, 2024. Mirum will also host a conference call to discuss the first quarter 2024 financial results and recent corporate progress....

at 16:15
Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today reported financial results for the first quarter 2024. "We are pleased to announce another strong quarter of growth from our four approved therapies,...

at 16:10
Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March...

at 16:10
Natera, Inc. , a global leader in cell-free DNA and genetic testing, today announced that it will release results for its first quarter ended March 31, 2024, after the market close on May 9, 2024. Natera will host a conference call and webcast...

at 16:10
Prothena Corporation plc , a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it will report its first quarter 2024 financial results on...



News published on and distributed by: